Perrigo Company plc
PRGOHealthcareNASDAQDrug Manufacturers - Specialty & Generic · Last scanned Jun 2, 2026
Scan Results
Daily timeframePerrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. With a market capitalization of $1.49B, it sits in small-cap territory. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments.
Market Cap
$1.49B
Beta
0.54
P/E (TTM)
—
P/E (Fwd)
4.56
EPS (TTM)
$-12.93
EPS (Fwd)
$2.36
ROE
-52.2%
ROA
2.1%
Cash
$357.2M
Total Debt
$3.83B
Free CF
$108.4M
52W Change
-59.4%
Annual Financials
Cash vs Debt
On the balance sheet, PRGO has $357.2M in cash with $3.83B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Annual free cash flow of $108.4M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at -52.2%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 2.1% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $4.45B (2022) to $4.25B (2025).
The relatively low beta of 0.54 suggests PRGO is a less volatile holding compared to the broader index. The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Perrigo Company plc's trajectory.